Immune-mediated disease rarely begins at the level at which it is diagnosed. A clinical phenotype is the visible consequence of disturbances that may begin with altered gene regulation, aberrant signaling, defective tolerance, metabolic stress, or disrupted communication between immune and tissue networks. Understanding those connections is central to understanding immunopathogenesis.
Molecular Immunopathogenesis: A Systems-Based Framework for Immune Homeostasis, Disease Mechanisms, and Translational Precision Medicine develops this perspective systematically. It treats immune-mediated disease not as a collection of unrelated disorders, but as the consequence of disturbed biological networks operating across molecular, cellular, tissue, and organ-system levels.
The framework begins with the architecture of immune homeostasis: how gene expression, epigenetic regulation, intracellular signaling, cellular metabolism, immune-cell interactions, tissue niches, and tolerance mechanisms maintain functional stability. From this foundation, the book examines how these regulatory systems become progressively destabilized and how that disruption generates persistent inflammation, altered immune recognition, tissue injury, and disease.
This systems perspective provides a common mechanistic language for understanding autoimmune disease, autoinflammatory disorders, hypersensitivity, immunodeficiency, infection, and cancer. It also clarifies why clinically similar diseases can arise through different molecular pathways, why biologically distinct diseases can converge on similar phenotypes, and why patients carrying the same diagnostic label may respond differently to therapy.
The book then follows immunopathogenesis into modern clinical translation. Molecular biomarkers, flow cytometry, sequencing, spatial biology, multi-omics, molecular classification, pharmacogenomics, targeted biologics, cellular therapies, gene editing, and RNA therapeutics are examined not as isolated technologies, but as tools for identifying and manipulating the biological networks underlying disease.
The result is a mechanism-centered account of immunology that connects molecular disturbance to cellular dysfunction, tissue pathology, clinical phenotype, diagnostic interpretation, and therapeutic selection. Rather than emphasizing memorization of individual diseases or pathways, the book develops a framework for recognizing how immune systems fail, how those failures propagate across biological scales, and how they can increasingly be measured and therapeutically redirected.
Written for medical students and biomedical scientists, with particular value for immunologists and clinical researchers, Molecular Immunopathogenesis provides an advanced but focused foundation for understanding contemporary immune-mediated disease and the transition from conventional diagnosis toward molecularly informed precision medicine.
The central proposition is simple but consequential: disease phenotype is the downstream expression of disturbed immune networks. Precision medicine begins when those disturbances can be identified at their biological source.
Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.
Vendeur : California Books, Miami, FL, Etats-Unis
Etat : New. N° de réf. du vendeur I-9781052183033
Quantité disponible : Plus de 20 disponibles
Vendeur : Grand Eagle Retail, Bensenville, IL, Etats-Unis
Paperback. Etat : new. Paperback. Immune-mediated disease rarely begins at the level at which it is diagnosed. A clinical phenotype is the visible consequence of disturbances that may begin with altered gene regulation, aberrant signaling, defective tolerance, metabolic stress, or disrupted communication between immune and tissue networks. Understanding those connections is central to understanding immunopathogenesis.Molecular Immunopathogenesis: A Systems-Based Framework for Immune Homeostasis, Disease Mechanisms, and Translational Precision Medicine develops this perspective systematically. It treats immune-mediated disease not as a collection of unrelated disorders, but as the consequence of disturbed biological networks operating across molecular, cellular, tissue, and organ-system levels.The framework begins with the architecture of immune homeostasis: how gene expression, epigenetic regulation, intracellular signaling, cellular metabolism, immune-cell interactions, tissue niches, and tolerance mechanisms maintain functional stability. From this foundation, the book examines how these regulatory systems become progressively destabilized and how that disruption generates persistent inflammation, altered immune recognition, tissue injury, and disease.This systems perspective provides a common mechanistic language for understanding autoimmune disease, autoinflammatory disorders, hypersensitivity, immunodeficiency, infection, and cancer. It also clarifies why clinically similar diseases can arise through different molecular pathways, why biologically distinct diseases can converge on similar phenotypes, and why patients carrying the same diagnostic label may respond differently to therapy.The book then follows immunopathogenesis into modern clinical translation. Molecular biomarkers, flow cytometry, sequencing, spatial biology, multi-omics, molecular classification, pharmacogenomics, targeted biologics, cellular therapies, gene editing, and RNA therapeutics are examined not as isolated technologies, but as tools for identifying and manipulating the biological networks underlying disease.The result is a mechanism-centered account of immunology that connects molecular disturbance to cellular dysfunction, tissue pathology, clinical phenotype, diagnostic interpretation, and therapeutic selection. Rather than emphasizing memorization of individual diseases or pathways, the book develops a framework for recognizing how immune systems fail, how those failures propagate across biological scales, and how they can increasingly be measured and therapeutically redirected.Written for medical students and biomedical scientists, with particular value for immunologists and clinical researchers, Molecular Immunopathogenesis provides an advanced but focused foundation for understanding contemporary immune-mediated disease and the transition from conventional diagnosis toward molecularly informed precision medicine.The central proposition is simple but consequential: disease phenotype is the downstream expression of disturbed immune networks. Precision medicine begins when those disturbances can be identified at their biological source. A systems-based examination of how disrupted immune homeostasis progresses from molecular and cellular dysfunction to tissue injury and disease-and how molecular diagnostics and targeted therapies are reshaping precision immunology. This item is printed on demand. Shipping may be from multiple locations in the US or from the UK, depending on stock availability. N° de réf. du vendeur 9781052183033
Quantité disponible : 1 disponible(s)
Vendeur : AussieBookSeller, Truganina, VIC, Australie
Paperback. Etat : new. Paperback. Immune-mediated disease rarely begins at the level at which it is diagnosed. A clinical phenotype is the visible consequence of disturbances that may begin with altered gene regulation, aberrant signaling, defective tolerance, metabolic stress, or disrupted communication between immune and tissue networks. Understanding those connections is central to understanding immunopathogenesis.Molecular Immunopathogenesis: A Systems-Based Framework for Immune Homeostasis, Disease Mechanisms, and Translational Precision Medicine develops this perspective systematically. It treats immune-mediated disease not as a collection of unrelated disorders, but as the consequence of disturbed biological networks operating across molecular, cellular, tissue, and organ-system levels.The framework begins with the architecture of immune homeostasis: how gene expression, epigenetic regulation, intracellular signaling, cellular metabolism, immune-cell interactions, tissue niches, and tolerance mechanisms maintain functional stability. From this foundation, the book examines how these regulatory systems become progressively destabilized and how that disruption generates persistent inflammation, altered immune recognition, tissue injury, and disease.This systems perspective provides a common mechanistic language for understanding autoimmune disease, autoinflammatory disorders, hypersensitivity, immunodeficiency, infection, and cancer. It also clarifies why clinically similar diseases can arise through different molecular pathways, why biologically distinct diseases can converge on similar phenotypes, and why patients carrying the same diagnostic label may respond differently to therapy.The book then follows immunopathogenesis into modern clinical translation. Molecular biomarkers, flow cytometry, sequencing, spatial biology, multi-omics, molecular classification, pharmacogenomics, targeted biologics, cellular therapies, gene editing, and RNA therapeutics are examined not as isolated technologies, but as tools for identifying and manipulating the biological networks underlying disease.The result is a mechanism-centered account of immunology that connects molecular disturbance to cellular dysfunction, tissue pathology, clinical phenotype, diagnostic interpretation, and therapeutic selection. Rather than emphasizing memorization of individual diseases or pathways, the book develops a framework for recognizing how immune systems fail, how those failures propagate across biological scales, and how they can increasingly be measured and therapeutically redirected.Written for medical students and biomedical scientists, with particular value for immunologists and clinical researchers, Molecular Immunopathogenesis provides an advanced but focused foundation for understanding contemporary immune-mediated disease and the transition from conventional diagnosis toward molecularly informed precision medicine.The central proposition is simple but consequential: disease phenotype is the downstream expression of disturbed immune networks. Precision medicine begins when those disturbances can be identified at their biological source. A systems-based examination of how disrupted immune homeostasis progresses from molecular and cellular dysfunction to tissue injury and disease-and how molecular diagnostics and targeted therapies are reshaping precision immunology. This item is printed on demand. Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability. N° de réf. du vendeur 9781052183033
Quantité disponible : 1 disponible(s)
Vendeur : PBShop.store US, Wood Dale, IL, Etats-Unis
PAP. Etat : New. New Book. Shipped from UK. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. N° de réf. du vendeur L0-9781052183033
Quantité disponible : Plus de 20 disponibles
Vendeur : PBShop.store UK, Fairford, GLOS, Royaume-Uni
PAP. Etat : New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. N° de réf. du vendeur L0-9781052183033
Quantité disponible : Plus de 20 disponibles
Vendeur : THE SAINT BOOKSTORE, Southport, Royaume-Uni
Etat : New. This item is printed on demand. New copy - Usually dispatched within 5-9 working days. N° de réf. du vendeur C9781052183033
Quantité disponible : Plus de 20 disponibles
Vendeur : CitiRetail, Stevenage, Royaume-Uni
Paperback. Etat : new. Paperback. Immune-mediated disease rarely begins at the level at which it is diagnosed. A clinical phenotype is the visible consequence of disturbances that may begin with altered gene regulation, aberrant signaling, defective tolerance, metabolic stress, or disrupted communication between immune and tissue networks. Understanding those connections is central to understanding immunopathogenesis.Molecular Immunopathogenesis: A Systems-Based Framework for Immune Homeostasis, Disease Mechanisms, and Translational Precision Medicine develops this perspective systematically. It treats immune-mediated disease not as a collection of unrelated disorders, but as the consequence of disturbed biological networks operating across molecular, cellular, tissue, and organ-system levels.The framework begins with the architecture of immune homeostasis: how gene expression, epigenetic regulation, intracellular signaling, cellular metabolism, immune-cell interactions, tissue niches, and tolerance mechanisms maintain functional stability. From this foundation, the book examines how these regulatory systems become progressively destabilized and how that disruption generates persistent inflammation, altered immune recognition, tissue injury, and disease.This systems perspective provides a common mechanistic language for understanding autoimmune disease, autoinflammatory disorders, hypersensitivity, immunodeficiency, infection, and cancer. It also clarifies why clinically similar diseases can arise through different molecular pathways, why biologically distinct diseases can converge on similar phenotypes, and why patients carrying the same diagnostic label may respond differently to therapy.The book then follows immunopathogenesis into modern clinical translation. Molecular biomarkers, flow cytometry, sequencing, spatial biology, multi-omics, molecular classification, pharmacogenomics, targeted biologics, cellular therapies, gene editing, and RNA therapeutics are examined not as isolated technologies, but as tools for identifying and manipulating the biological networks underlying disease.The result is a mechanism-centered account of immunology that connects molecular disturbance to cellular dysfunction, tissue pathology, clinical phenotype, diagnostic interpretation, and therapeutic selection. Rather than emphasizing memorization of individual diseases or pathways, the book develops a framework for recognizing how immune systems fail, how those failures propagate across biological scales, and how they can increasingly be measured and therapeutically redirected.Written for medical students and biomedical scientists, with particular value for immunologists and clinical researchers, Molecular Immunopathogenesis provides an advanced but focused foundation for understanding contemporary immune-mediated disease and the transition from conventional diagnosis toward molecularly informed precision medicine.The central proposition is simple but consequential: disease phenotype is the downstream expression of disturbed immune networks. Precision medicine begins when those disturbances can be identified at their biological source. A systems-based examination of how disrupted immune homeostasis progresses from molecular and cellular dysfunction to tissue injury and disease-and how molecular diagnostics and targeted therapies are reshaping precision immunology. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability. N° de réf. du vendeur 9781052183033
Quantité disponible : 1 disponible(s)
Vendeur : AHA-BUCH GmbH, Einbeck, Allemagne
Taschenbuch. Etat : Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - A systems-based examination of how disrupted immune homeostasis progresses from molecular and cellular dysfunction to tissue injury and disease-and how molecular diagnostics and targeted therapies are reshaping precision immunology. N° de réf. du vendeur 9781052183033
Quantité disponible : 2 disponible(s)
Vendeur : preigu, Osnabrück, Allemagne
Taschenbuch. Etat : Neu. Molecular Immunopathogenesis | A Systems-Based Framework for Immune Homeostasis, Disease Mechanisms, and Precision Medicine | MD Ishikawa Fujimoto | Taschenbuch | Englisch | 2026 | Ishikawa Fujimoto, MD | EAN 9781052183033 | Verantwortliche Person für die EU: Libri GmbH, Europaallee 1, 36244 Bad Hersfeld, gpsr[at]libri[dot]de | Anbieter: preigu Print on Demand. N° de réf. du vendeur 136974373
Quantité disponible : 5 disponible(s)